1. Home
  2. AYTU vs MSPR Comparison

AYTU vs MSPR Comparison

Compare AYTU & MSPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AYTU
  • MSPR
  • Stock Information
  • Founded
  • AYTU N/A
  • MSPR 2014
  • Country
  • AYTU United States
  • MSPR United States
  • Employees
  • AYTU N/A
  • MSPR N/A
  • Industry
  • AYTU Biotechnology: Pharmaceutical Preparations
  • MSPR
  • Sector
  • AYTU Health Care
  • MSPR
  • Exchange
  • AYTU Nasdaq
  • MSPR NYSE
  • Market Cap
  • AYTU 9.6M
  • MSPR 7.8M
  • IPO Year
  • AYTU N/A
  • MSPR N/A
  • Fundamental
  • Price
  • AYTU $2.10
  • MSPR $1.23
  • Analyst Decision
  • AYTU
  • MSPR
  • Analyst Count
  • AYTU 0
  • MSPR 0
  • Target Price
  • AYTU N/A
  • MSPR N/A
  • AVG Volume (30 Days)
  • AYTU 624.8K
  • MSPR 47.9K
  • Earning Date
  • AYTU 05-14-2025
  • MSPR 08-13-2025
  • Dividend Yield
  • AYTU N/A
  • MSPR N/A
  • EPS Growth
  • AYTU N/A
  • MSPR N/A
  • EPS
  • AYTU N/A
  • MSPR N/A
  • Revenue
  • AYTU $81,659,000.00
  • MSPR $13,085,000.00
  • Revenue This Year
  • AYTU N/A
  • MSPR N/A
  • Revenue Next Year
  • AYTU $8.68
  • MSPR N/A
  • P/E Ratio
  • AYTU $11.39
  • MSPR N/A
  • Revenue Growth
  • AYTU 0.41
  • MSPR 34.74
  • 52 Week Low
  • AYTU $0.95
  • MSPR $1.10
  • 52 Week High
  • AYTU $2.96
  • MSPR $13.50
  • Technical
  • Relative Strength Index (RSI)
  • AYTU 60.77
  • MSPR N/A
  • Support Level
  • AYTU $1.97
  • MSPR N/A
  • Resistance Level
  • AYTU $2.17
  • MSPR N/A
  • Average True Range (ATR)
  • AYTU 0.14
  • MSPR 0.00
  • MACD
  • AYTU 0.00
  • MSPR 0.00
  • Stochastic Oscillator
  • AYTU 58.33
  • MSPR 0.00

About AYTU Aytu BioPharma Inc.

Aytu BioPharma Inc is a specialty pharmaceutical company with a commercial portfolio of prescription therapeutics and consumer health products. The company's primary prescription products treat attention deficit hyperactivity disorder and other common pediatric conditions. It is building a complementary therapeutic development pipeline including a prospective treatment (AR101/enzastaurin) for vascular Ehlers-Danlos Syndrome, a rare genetic disease resulting in high morbidity and a significantly shortened lifespan. The company operates in two segments Rx Segment, consisting of prescription pharmaceutical products and Consumer Health segments of which the company generates maximum revenue from the Rx segment.

About MSPR MSP RECOVERY INC

MSP Recovery Inc is a healthcare recovery and data analytics company. The business model includes two principal lines of business: Claims Recovery and Chase to Pay Services. It offers an antiquated healthcare reimbursement system with data-driven solutions to secure recoveries against responsible parties. MSP Recovery provides the healthcare industry with comprehensive compliance solutions platform to recover any claims where the law places primary payment responsibility on another payer.

Share on Social Networks: